10 февраля 2026 года
Новый раунд: $118M
“Garner Health is the best way to reduce costs, improve employee engagement, and incorporate value-based care into your benefits program.”
Новый раунд: $115M
“ILiAD Biotechnologies is a clinical stage biotechnology company dedicated to the prevention and treatment of diseases caused by Bordetella Pertussis. Our lead candidate, BPZE1, represents the most advanced next generation pertussis vaccine, successfully completing two Phase 2 clinical trials. Join us in advancing public health through innovative vaccine solutions.”
Новый раунд: $99.77M
“Revolutionize orthodontics with AI-powered solutions. Monitor patients, optimize workflows, and enhance care quality while driving practice growth and efficiency.”
Новый раунд: $80M
“Deep Fission Nuclear Energy Solutions”
Новый раунд: $75M
“Eliminate risks and alerts queues with audit ready agents that work inside of your existing compliance systems.”
Новый раунд: $72.32M
“Kaisikaidi (Shanghai) Medical Technology Co., Ltd. -Kaisikaidi (Shanghai) Medical Technology Co., Ltd.”